title: Reducing the global burden of tuberculosis: the contribution of improved diagnostics.
authors.affiliation: RAND Corporation, 1776 Main Street, PO Box 2138, Santa Monica, California 90407-2138, USA.
authors.forename: Emmett
authors.initials: E
authors.lastname: Keeler
authors.forename: Mark D
authors.initials: MD
authors.lastname: Perkins
authors.forename: Peter
authors.initials: P
authors.lastname: Small
authors.forename: Christy
authors.initials: C
authors.lastname: Hanson
authors.forename: Steven
authors.initials: S
authors.lastname: Reed
authors.forename: Jane
authors.initials: J
authors.lastname: Cunningham
authors.forename: Julia E
authors.initials: JE
authors.lastname: Aledort
authors.forename: Lee
authors.initials: L
authors.lastname: Hillborne
authors.forename: Maria E
authors.initials: ME
authors.lastname: Rafael
authors.forename: Federico
authors.initials: F
authors.lastname: Girosi
authors.forename: Christopher
authors.initials: C
authors.lastname: Dye
mesh_terms: D000995:Antitubercular Agents; D017281:Cost of Illness; D003663:Decision Trees; D003906:Developing Countries; D019937:Diagnostic Techniques and Procedures; D023801:Directly Observed Therapy; D014943:Global Health; D006801:Humans; D008828:Microbiological Techniques; D008962:Models, Theoretical; D009169:Mycobacterium tuberculosis / Q000302:isolation & purification; D014374:Tuberculin Test; D014376:Tuberculosis / Q000175:diagnosis* / Q000188:drug therapy / Q000453:epidemiology / Q000517:prevention & control
chemical_list: D000995:Antitubercular Agents